An osteogenic cell culture system to evaluate the cytocompatibility of osteoset(®), a calcium sulfate bone void filler

Biomaterials

Volumn 21, Issue 23, 2000, Pages 2413-2425

  Winn, Shelley R ^a   Hollinger, Jeffrey O ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Biomaterials; Bone regeneration; Osteogenic; OsteoSet( ) pellets; Recombinant human bone morphogenetic protein 2 (rhBMP 2); Transwell( ) inserts

Indexed keywords

ANIMAL CELL CULTURE; BIOCOMPATIBILITY; BONE; CALCIUM COMPOUNDS; CYTOLOGY; FILLERS; GRAFTS; PROTEINS; TISSUE CULTURE;

CALCIUM SULFATE; CELL PROLIFERATION;

BIOMATERIALS;

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; CALCIUM SULFATE; RECOMBINANT PROTEIN;

ARTICLE; BIOCOMPATIBILITY; BONE GRAFT; BONE REGENERATION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0034580469     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00109-5     Document Type: Article

References (35)

1. Friedlaender G.E. Current concepts review. bone grafts: the basic science rationale for clinical appliications J Bone J Surg. 69A:1987;786-790.
2. Mayer M.H. Clinical perspectives on bone grafting. avoiding the complications of developmental malformations Seyfer A., Hollinger J. bone repair and regeneration. Vol. 21:1994;365-376 W.B. Saunders, Philadelphia.
3. Harakas N.K. Demineralized bone matrix-induced osteogenesis. Clin Orthop Rel Res. 188:1984;239-251.
4. Matukas V.J., Clanton J.T., Langford K.H., Aronin P.A. Hydroxylapatite. an adjunct to cranial bone grafting J Neurosurg. 69:1988;514-517.
5. Kadiyala S., Lo H., Leong K. Biodegradable polymers as synthetic bone grafts. Brighton C.T., Friedlaender G., Lane J.M. Bone Formation and Repair. 1994;316-324 American Academy of Orthopaedic Surgeons, Rosemont.
6. Hollinger J.O., Mayer M., Buck D., Zegzula H.D., Ron E., Smith J., Lin L., Wozney J. Poly(alpha-hydroxy acid) carrier for delivering recombinant human bone morphogenetic protein-2 for bone regeneration. J Controlled Rel. 39:1996;287-304.
7. Tomford W. Current concepts review. Transmission of disease through transplantation of musculoskeletal allografts. J Bone J Surg. 77-A:1995;1742-1754.
8. Langer R., Vacanti J.P. Tissue engineering. Science. 260:1993;920-926.
9. Hubbell J.A. Biomaterials in tissue engineering. Biotechnology. 13:1995;565-576.
10. Winn S.R., Uludag H., Hollinger J.O. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev. 31:1998;303-318.
11. Hollinger J.O., Buck D.C., Bruder S. Biology of bone healing. its impact on clinical therapy Lynch R.G.S., Marx R. Tissue Engineering. applications in maxillofacial surgery and periodontics:1998;17-53 Quintessence, San Diego.
12. Winn S.R., Schmitt J.M., Buck D., Hu Y., Grainger D., Hollinger J.O. A tissue engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats. J Biomed Mater Res. 45:1999;414-421.
13. Frankel A.H., Sayegh M.H., Rothstein D.M., Milford E.L., Carpenter C.B. Requirements for the induction of allospecific CD8+ suppressor T cells in the rat primary mixed lymphocyte response. CD4+, CD45R+ T cells, or supernatant factor. Transplantation. 48:1989;639-646.
14. Katoh M., Kitamura K., Kitagawa H. Induction of bone resorbing-activity by mouse stromal cell line, MC3T3-G2/PA6. Bone. 16:1995;97-102.
15. Israel D.I., Nove J., Kerns K.M., Moutsatsis I.K., Kaufman R.J. Expression and characterization of bone morphogenetic proteins-2 in chinese hamster ovary cells. Growth Factors. 7:1992;139-150.
16. Winn S.R., Randolph G., Uludag H., Wong S.C., Hair G.A., Hollinger J.O. Establishing an immortalized human osteoprecursor cell line. OPC1 J Bone Min Res. 14:1999;1721-1733.
17. Sudo H., Kodama H., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newnorn mouse calvaria. J Cell Biol. 96:1983;191-198.
18. Bruder S.P., Jaiswal N., Haynesworth S.E. Growth kinetics, self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem. 64:1997;278-294.
19. Lowry O.H., Roberts N.R., Wu M.-L, Hixson W.S., Crawford E.J. The quantitative histochemistry of brain. Enzyme measurements. J Biol Chem. 207:1954;19-37.
20. Pilkington G.J., Bjerkvig R., De Ridder L., Kaaijk P. In vitro and in vivo models for the study of brain tumour invasion. Anticancer Res. 17:1997;4107-4109.
21. Saad B., Ciardelli G., Matter S., Welti M., Uhlschmid G.K., Neuenschwander P., Suter U.W. Degradbable and highly porous polyesterurethane foam as biomaterial. effects and phagocytosis of degradation products in osteoblasts J Biomed Mater Res. 39:1998;594-602.
22. Papaioannou W., Cassiman J.J., Van den Oord J., De Vos R., van Steenberghe D., Quirynen M. Multi-layered periodontal pocket epithelium reconstituted in vitro. histology and cytokeratin profiles J Periodont. 70:1999;668-678.
23. Puleo D.A., Holleran L.A., Doremus R.H., Bizios R. Osteoblast responses to orthopedic implant materials in vitro. J Biomed Mater Res. 25:1991;711-723.
24. Brook I., Craig G., Hatton P. Bone cell interation with a granular glass-ionomer bone substitute material. in vivo and in vitro culture models Biomaterials. 13:1992;721-725.
25. Begley C.T., Doherty M.J., Hankey D.P., Wilson D.J. The culture of human osteoblasts upon bone graft substitutes. Bone. 14:1993;661-666.
26. Puleo D.A., Preston K.E., Schaffer J.B. Bizios. Examination of osteoblast-orthopaedic biomaterial interactions using molecular techniques. Biomaterials. 14:1993;111-114.
27. Elgendy H.M., Norman M.E., Keaton A.R., Laurencin C.T. Osteoblast-like cell (MC3T3-E1) proliferation on bioerodible polymers. an approach towards development of a bone-erodible polymer composite material Biomaterials. 14:1993;263-269.
28. Ishaug S.L., Yaszemski M.J., Bizios R., Mikos A.G. Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res. 28:1994;1445-1453.
29. Sidqui M., Collin P., Vitte C., Forest N. Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate. Biomaterials. 16:1995;1327-1332.
30. Saad B., Matter S., Ciardelli G., Uhlschmid G.K., Welti M., Neuenschwander P., Suter U.W. Interactions of osteoblasts and macrophages with biodegradble and highly porous polyesterurethane foam and its degradation products. J Biomed Mater Res. 32:1996;355-366.
31. Yoshimine Y., Sumi M., Isobe R., Anan H., Maeda K. In vitro interaction between tetracalcium phosphate-based cement and calvarial osteogenic cells. Biomaterials. 17:1996;2241-2245.
32. Hott M., Noel B., Bernache-Assolant D., Rey C., Marie P.J. Proliferation and differentiation of human trabecular osteoblastic cells on hydroxyapatite. J Biomed Mater Res. 37:1997;508-516.
33. Kim C.K., Kim H.Y., Chai J.K., Cho K.S., Moon I.S., Choi S.H., Sottosanti J.S., Wikesjo U.M. Effect of a calcium sulfate implant with calcium sulfate barrier on periodontal healing in 3-wall intrabony defectrs in dogs. J Periodont. 69:1998;982-988.
34. Pecora G.E., De Leonardis D., Della Rocca C., Cornelini R., Cortesini C. Short-term healing following the use of calcium sulfate as a grafting materials for sinus augmentation. a clinical report Int J Oral and Max Imp. 13:1998;866-873.
35. Bai M.H., Liu X.Y., Ge B.F., Yallg C., Chen D.A. An implant of a composite of bovine bone morphogenetic protein and plaster of paris for treatment of femoral shaft nonunions. Int Surg. 81:1996;390-392.